Hogan Lovells advises Shop Apotheke Europe N.V. on placement of EUR 225 million convertible bonds

Led by Frankfurt-based Partner Michael Schlitt, international law firm Hogan Lovells has advised Shop Apotheke Europe N.V., one of Europe's leading and fastest-growing online pharmacies, on the placement with institutional investors of senior unsecured convertible bonds, with a maturity of seven years and an aggregate principal amount of EUR 225 million.

The bonds do not bear interest. The initial conversion price was set at EUR 233.83, this represents a premium of 50.0 per cent to the volume-weighted average share price during the bookbuilding process on January 14, 2021. The Company intends to use the proceeds from the offering for general corporate purposes. The convertible bonds are expected to be included promptly in trading on the Open Market of the Frankfurt Stock Exchange. 

Goldman Sachs Bank Europe SE acted as Sole Global Coordinator and Sole Bookrunner for the issuance and placement.

Hogan Lovells team for Shop Apotheke Europe N.V. 


Prof. Dr. Michael Schlitt (Partner), Dr. Susanne Ries (Of Counsel), Mark Devlin (Counsel), Dr. Timo Lockemann, Christian Schröder (Associates), Eva-Christina Sommer, Simona Gradišek (Business Lawyers) (all Capital Markets);


Dr. Heiko Gemmel (Partner), Anne-Svenja de Kiff (Counsel) (all Tax);


Victor de Vlaam (Partner), Aafke Pronk (Counsel), Leonie Huisman (Counsel), Janelle de Ruiter, Georgi Yavorov Boyadzhiev (Associates) (all Corporate);

Alexander Fortuin (Partner, Tax);


Jonathan Baird (Partner, US Law, London).

Inhouse Shop Apotheke Europe N.V.: Rens Jan Kramer, Alain Probst

Back To Listing